Daily aspirin to prevent heart disease and stroke no longer recommended for people 60 and older

A daily aspirin is no longer recommended for people 60 and older because of potential health risks, the U.S. Preventive Services Task Force announced Tuesday.

The new advice is an update to 2016 guidance that said people between 60 and 69 years old with at least a 10% risk of suffering from cardiovascular disease over the next 10 years should view taking low-dose aspirin daily as an “individual” decision.

“Based on new evidence since the 2016 task force recommendation, it is now recommended that once people turn 60 years old, they should not consider starting to take aspirin because the risk of bleeding cancels out the benefits of preventing heart disease,” the task force stated.

Meanwhile, those 40 to 59 with at least a 10% risk of 10-year cardiovascular disease should look at taking daily aspirin as an individual choice, the task force said.

“Daily aspirin use may help prevent heart attacks and strokes in some people, but it can also cause potentially serious harms, such as internal bleeding,” John Wong, a member of the task force, said in a statement.

“It’s important that people who are 40 to 59 years old and don’t have a history of heart disease have a conversation with their clinician to decide together if starting to take aspirin is right for them.”

The new guidelines apply to people who don’t have cardiovascular disease but are at high risk to develop it and haven’t begun taking aspirin each day, the task force says.

The organization also notes about 605,000 people in the U.S. suffer their first heart attack each year on average, while about 610,000 have their first stroke. Heart disease accounts for more than 25% of deaths in the U.S., making it the leading cause in the country, according to the group.

Aspirin is an anti-inflammatory that has been used for more than a century. It’s often taken to treat symptoms including headaches, body aches and other cold-like ailments.

The task force is made up of 16 appointed volunteers who are each considered leaders within a field of health or medicine.